An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 4, 2013, Pages 613-621

  Terada, Tadashi ^a  

^a SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

Author keywords

Colorectum; Histopathology; Immunohistochemistry; MUC; Mucins; Signet ring cell carcinoma; Stomach

Indexed keywords

MUC1 PROTEIN, HUMAN; MUC2 PROTEIN, HUMAN; MUC5AC PROTEIN, HUMAN; MUC6 PROTEIN, HUMAN; MUCIN; MUCIN 1; MUCIN 2; MUCIN 5AC; MUCIN 6; TUMOR MARKER;

AGED; ARTICLE; CASE CONTROL STUDY; COLORECTAL TUMOR; COLORECTUM; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MUC; MUCOSA; PATHOLOGY; SIGNET RING CARCINOMA; SIGNET-RING CELL CARCINOMA; STOMACH; STOMACH TUMOR; VERY ELDERLY;

COLORECTUM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MUC; MUCINS; SIGNET-RING CELL CARCINOMA; STOMACH;

AGED; AGED, 80 AND OVER; CARCINOMA, SIGNET RING CELL; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCIN 5AC; MUCIN-1; MUCIN-2; MUCIN-6; MUCOUS MEMBRANE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84879884494     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Itoh Y, Kamata-Sakurai M, Denda-Nagai K, Nagai S, Tsuiji M, Ishii-Schrade K, Okada K, Goto A, Fukayama M, Irimura T. Identification and expression of human epiglycanin/MUC21: a novel transmembrane mucin. Glycobiology 2008; 18: 74-83.
2. Andrianifahanana M, Moniaux N, Batra SK. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta 2006; 1765: 189-222.
3. Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 2004; 23: 77-99.
4. Kocer B, Soran A, Erdogan S, Karabeyoglu M, Yildirim O, Eroglu A, Bozkurt B, Cengiz O. Expression of MUC5AC in colorectal carcinoma and relationship with prognosis. Pathol Int 2002; 52: 470-477.
5. Kocer B, Soran A, Erdogan S, Karabeyoglu M, Yildirim O, Eroglu A, Bozkurt B, Cengiz O. Expression of MUC5AC in colorectal carcinoma and relationship with prognosis. Pathol Int 2002; 52: 470-477.
6. Lauwers GY, Franceschi S, Carneiro F, Montgomery E, Graham DY, Tatematsu M, Curado MP, Hattori T. Gastric carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND eds. WHO classification of tumours of the the digestive organs. IARC; Lyon, 2010. pp: 48-58.
7. Hamilton SR, Nakamura S, Bosman FT, Quirke P, Boffetta P, Riboli E, IIyas M, Sobin LH, Morreau H. Carcinoma of the colon and rectum. In: Bosman FT, Carneiro F, Hruban RH, Theise ND eds. WHO classification of tumours of the the digestive organs. IARC; Lyon, 2010. pp: 134- 146.
8. Terada T. Primary signet-ring cell carcinoma of the lung: a case report with an immunohistochemical study. Int J Clin Exp Pathol 2012; 5: 171-174.
9. Terada T. Primary signet-ring cell carcinoma of the ampulla of Vater: a case report with an immunohistochemical study. Appl Immunohistochem Mol Morphol 2012; 20: 427-428.
10. Terada T. Primary signet-ring cell carcinoma of the pancreas diagnosed by endoscopic retrograde pancreatic duct biopsy: a case report. Endoscopy 2012; 44 Suppl 2: E141-142.
11. Terada T. Primary pure signet ring cell adenocarcinoma of the non-Barrett's esophagus: a case report with immunohistochemical study. Endoscopy 2011; 43: E397-8.
12. Terada T. Primary pure signet-ring cell adenocarcinoma of the urinary bladder: a report of three cases with an immunohistochemical study. Med Oncol 2012; 29: 2866-9.
13. Terada T. Signet-ring cell carcinoma of the non-ampullary duodenum and proximal jejunum: a case report with an immunohistochemical study. Endoscopy (in press).
14. Terada T. Primary pure signet-ring cell carcinoma of the anus: a case report with immunohistochemical study. Endoscopy (in press).
15. Terada T. An immunohistochemical study of a primary signet-ring cell carcinoma of the ampulla of Vater: A case report. J Gastrointest Cancer 2012 Dec 19; Epub ahead of print.
16. Terada T. Signet-ring cell carcinoma of the esophagus in dermatomyositis: a case report with immunohistochemical study. J Gastrointest Cancer (in press).
17. Terada T. Ovarian malignant Mullerian mixed tumor (heterologous) whose epithelial component is composed predominantly of signet ring cell carcinoma. Arch Gynecol Obstet 2011; 283: 1403-1406.
18. Terada T. Small Cell Carcinoma of the Ileum That Developed 10 Years After Total Gastrectomy for Gastric Signet-ring Cell Carcinoma. Appl Immunohistochem Mol Morphol 2012; 20: 618-619.
19. Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sigihara K. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 2000; 89: 724-732.
20. Ilhan O, Han U, Onal B, Celik SY. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma. Turk J Gastroenterol 2010; 21: 345-352.
21. Tsukashita S, Kushima R, Bamba M, Sugihara H, Hattori T. MUC gene expression and histogenesis of adenocarcinoma of the. stomach 2001; 94: 166-170.
22. Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 2004; 23: 77-99.
23. Bu XD, Li N, Tian XG, Li L, Wang JS, Yu XJ, Huang PL. Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. World J Gastroenterol 2010; 16: 4089-4094.
24. Nguyen MD, Plasil B, Wen P, Frankle WL. Mucin profiles in signet-ring cell carcinoma. Arch Pathol Lab Med 2006; 130: 799-804.
25. Hayashi H, Kitamura H, Nakatani Y, Inayama Y, Ito T, Kiutamura H. Primary signet-ring cell carcinoma of the lung: histochemical and immunohistochemical characterization. Hum Pathol 1999; 30: 378-383.
26. Terada T. Well differentiated adenocarcinoma of the stomach composed of chief cell-like cells and parietal cells (Gastric adenocarcinoma of fundic gland type). Int J Clin Exp Pathol 2011; 4: 797-798.
27. Terada T. Pathologic observations of the duodenum in 615 consecutive duodenal specimens: I. Benign lesions. Int J Clin Exp Pathol 2012; 5: 46-51.
28. Terada T. Pathologic observations of the duodenum in 615 consecutive duodenal specimens in a single Japanese hospital: II. Malignant lesions. Int J Clin Exp Pathol 2012; 5: 52-57.
29. Terada T. Malignant tumors of the small intestine: A histopathologic study of 41 cases among 1,312 consecutive specimens of small intestine. Int J Clin Exp Pathol 2012; 5: 203-209.
30. Terada T. A clinical-histopathologic study of esophageal 860 benign and malignant lesions in 910 cases of consecutive esophageal biopsies. Int J Clin Exp Pathol 2013; 6: 191-198.